Literature DB >> 1202494

Haematoporphyrins in the diagnosis and treatment of carcinoma of the bladder.

J F Kelly.   

Abstract

The localization of an haematoporphyrin derivative (HpD) was studied in the operative specimens of three patients with carcinoma of the bladder. The drug was found to localize preferentially in malignant and premalignant mucosa and not in normal bladder tissues. It is suggested that HpD fluorescence might be useful as a diagnostic aid and its photosensitizing properties be used as a mode of therapy for carcinoma of the bladder.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1202494      PMCID： PMC1863830     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


  5 in total

1.  The use of a derivative of hematoporhyrin in tumor detection.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Natl Cancer Inst       Date:  1961-01       Impact factor: 13.506

2.  Photodynamic therapy of malignant tumours.

Authors:  I Diamond; S G Granelli; A F McDonagh; S Nielsen; C B Wilson; R Jaenicke
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

3.  Hematoporphyrin-derivative-fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia, and carcinoma in situ of the cervix uteri.

Authors:  G A Kyriazis; H Balin; R L Lipson
Journal:  Am J Obstet Gynecol       Date:  1973-10-01       Impact factor: 8.661

4.  Hematoporphyrin fluorescence: an aid in diagnosis of malignant neoplasms.

Authors:  J R Leonard; W L Beck
Journal:  Laryngoscope       Date:  1971-03       Impact factor: 3.325

5.  Photodynamic destruction of human bladder carcinoma.

Authors:  J F Kelly; M E Snell; M C Berenbaum
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640
  5 in total
  2 in total

1.  Application of new technology in bladder cancer diagnosis and treatment.

Authors:  Alvin C Goh; Seth P Lerner
Journal:  World J Urol       Date:  2009-02-22       Impact factor: 4.226

2.  [Photodynamic therapy with verteporfin for uveal melanoma].

Authors:  J Wachtlin; N E Bechrakis; M H Foerster
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.